首页 > 市场调查报告书 > 医疗设备

眼科设备

市场调查报告书

商品编码

1858992

眼科器材市场机会、成长驱动因素、产业趋势分析及预测（2025-2034年）

Ophthalmic Devices Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025 - 2034

出版日期: 2025年10月13日 | 出版商:

Global Market Insights Inc. | 英文 140 Pages | 商品交期: 2-3个工作天内

价格

简介目录

2024 年全球眼科设备市场价值为 487 亿美元，预计到 2034 年将以 4.2% 的复合年增长率增长至 727 亿美元。

市场成长的驱动力来自于对微创治疗需求的不断增长、眼部疾病盛行率的上升以及人口老化的加剧。技术进步显着提升了诊断和手术方法，提高了诊断的准确性和患者的治疗效果。人工智慧驱动的成像平台、雷射手术和光学相干断层扫描等先进系统能够更快地检测并更有效地治疗视力问题。智慧隐形眼镜和穿戴式视力辅助设备的日益普及进一步提升了患者的便利性和治疗效果。随着诊断、影像和手术设备的不断进步，眼科护理变得更加精准、经济高效且易于获取。全球对视力健康的日益重视以及常规眼科检查的增加，正在扩大客户群。生活方式的改变、萤幕使用时间的增加以及更长的数位互动导致视力障碍显着增加，促使更多人寻求视力保健解决方案。这些因素，加上数位科技在医疗保健领域的日益整合，必将推动未来几年市场的发展。

市场范围
起始年份	2024
预测年份	2025-2034
起始值	487亿美元
预测值	727亿美元
复合年增长率	4.2%

2024年，视力保健产品市占率达51.9%。其中，隐形眼镜和眼镜片等子类别的需求持续强劲，这主要得益于长时间接触电子萤幕的使用者对视力问题的日益关注。使用者倾向于选择具有光线调节、防眩光和蓝光过滤等附加功能的专业镜片，以提高萤幕使用和户外活动时的舒适度。眼镜片尤其受到近视和远视等屈光不正患者的青睐，他们希望找到既能矫正视力又能满足时尚需求的个人化解决方案。

到2024年，消费者市场将占据47.8%的份额，这主要得益于年轻人对视力矫正工具使用量的增加。随着人们对萤幕的依赖性日益增强，尤其是在年轻人和上班族群体中，时尚、高效且易于购买的眼镜需求明显增加。用户积极寻求便利的选择，例如订阅式镜片配送、虚拟试戴和线上配镜，所有这些都促进了市场扩张。这一趋势正在重塑消费者的购买体验，并促使製造商在功能和时尚之间进行创新。

2024年，北美眼科器材市场占36.8%的份额。该地区的领先地位得益于其强大的医疗保健基础设施、日益增强的眼睛健康意识以及对新技术的积极接受。人口老化导致青光眼、白内障和视网膜疾病等眼科疾病风险增加，也推动了对先进眼科治疗的需求。医疗保险的普及和优惠的报销政策提高了手术和诊断程序的可及性，进一步提升了该地区的市场渗透率。

眼科器材市场的主要参与者包括爱尔康 (Alcon)、博士伦 (Bausch+Lomb)、库博光学 (CooperVision)、强生 (Johnson & Johnson)、尼德克 (NIDEK)、豪雅 (HOYA)、拓普康医疗 (TOPCON Healthcare)、海涅 (HEINE)、欧菲泰克 (Ophtec)、JJISS GISS」、EJISS GISS GISS GJISS GISS GJV (Ophtec (COBURN TECHNOLOGIES)、佳能 (Canon)、依视路 (Essilor)、齐默眼科 (Ziemer OPHTHALMOLOGY) 和维信尼克斯 (VISIONIX)。全球眼科器材市场的企业正致力于产品创新、拓展全球业务并提升客户互动。他们大力投资研发，力求将整合人工智慧、智慧穿戴装置和增强成像功能的下一代设备推向市场。与诊所、医院和零售网络建立策略合作伙伴关係有助于扩大其分销网络。各公司也透过数位化平台强调个人化解决方案，提供远距眼科检查、电子处方和虚拟试戴工具。为了满足价格敏感型市场的需求，许多公司正在拓展产品组合，提供兼具成本效益和先进性的产品选择。

产业生态系分析
产业影响因素
- 成长驱动因素
  - 眼科疾病患者人数增加
  - 产品技术进步
  - 有利的政府倡议
  - 人们对微创手术的需求和偏好日益增长
  - 隐形眼镜和眼镜的普及率不断上升
- 产业陷阱与挑战
  - 眼科设备价格昂贵
  - 翻新眼科设备的使用率不断提高
- 机会
  - 高端人工水晶体和超音波乳化设备的使用日益普及。
  - 新兴市场的扩张
成长潜力分析
监管环境
- 北美洲
- 欧洲
- 亚太地区
技术与创新格局
- 当前技术趋势
- 新兴技术
消费者行为趋势
2024年各地区定价分析
永续性和环境影响
- 使用可回收材料
- 节能型製造工艺
投资环境
波特的分析
PESTEL 分析
未来市场趋势
价值链分析

第四章：竞争格局

介绍
公司矩阵分析
公司市占率分析
- 全球的
- 北美洲
- 欧洲
主要市场参与者的竞争分析
竞争定位矩阵
战略仪錶板
关键进展
- 併购
- 合作伙伴关係与合作
- 新产品发布
- 扩张计划

第五章：市场估算与预测：依产品划分，2021-2034年

主要趋势
视力保健产品
- 隐形眼镜
  - 软性隐形眼镜
  - 硬式透气性隐形眼镜（RGP）
  - 托里卡
  - 其他隐形眼镜
- 眼镜镜片
外科器械
- 白内障手术器械
  - 人工水晶体
  - 超音波乳化装置
  - 眼科黏弹性装置
  - 白内障手术雷射
  - IOL注射器
  - 其他白内障手术器械
- 青光眼手术器械
  - 青光眼引流装置
  - 青光眼雷射
  - 微创青光眼手术（MIGS）
  - 其他青光眼手术设备
- 屈光手术器械
  - 准分子雷射
  - 飞秒雷射
  - 其他屈光手术器械
- 玻璃体视网膜手术器械
  - 光凝雷射
  - 照明设备
  - 玻璃体视网膜包
  - 玻璃体切除机
  - 玻璃体切除探针
  - 其他玻璃体视网膜手术器械
诊断和监测设备
眼科配件

第六章：市场估算与预测：依最终用途划分，2021-2034年

主要趋势
消费者
医院
专科诊所
门诊手术中心
其他用途

第七章：市场估计与预测：依地区划分，2021-2034年

主要趋势
北美洲
- 我们
- 加拿大
欧洲
- 德国
- 英国
- 法国
- 西班牙
- 义大利
- 荷兰
亚太地区
- 中国
- 日本
- 印度
- 澳洲
- 韩国
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
MEA
- 南非
- 沙乌地阿拉伯
- 阿联酋

第八章：公司简介

Alcon
Bausch+Lomb
Canon
COBURN TECHNOLOGIES
CooperVision
Essilor
HAAG-STREIT GROUP
HEINE
HOYA
Johnson & Johnson
NIDEK
ophtec
TOPCON Healthcare
VISIONIX
ZEISS
ziemer OPHTHALMOLOGY

简介目录

Product Code: 2917

The Global Ophthalmic Devices Market was valued at USD 48.7 billion in 2024 and is estimated to grow at a CAGR of 4.2% to reach USD 72.7 billion by 2034.

Market growth is being propelled by increasing demand for minimally invasive treatments, rising prevalence of eye-related disorders, and a surge in the aging population. Technological progress has significantly advanced diagnostic and surgical methods, improving both accuracy and patient outcomes. Sophisticated systems like AI-driven imaging platforms, laser-based procedures, and optical coherence tools are enabling quicker detection and more efficient treatment of vision conditions. The increasing use of smart lenses and wearable vision aids is further improving patient convenience and outcomes. With ongoing advancements in diagnostics, imaging, and surgical equipment, eye care is becoming more precise, cost-effective, and accessible. Rising global awareness of vision health, combined with an increase in routine eye check-ups, is contributing to a larger customer base. Lifestyle shifts, increased screen exposure, and longer digital engagement have led to a notable rise in vision impairments, prompting more people to adopt vision care solutions. These factors, combined with growing integration of digital technologies in healthcare, are set to enhance the market trajectory in the years ahead.

Market Scope
Start Year	2024
Forecast Year	2025-2034
Start Value	$48.7 Billion
Forecast Value	$72.7 Billion
CAGR	4.2%

The vision care products segment held a 51.9% share in 2024. Subcategories include contact lenses and spectacle lenses, which continue to witness strong demand due to the surge in vision-related concerns among users exposed to digital screens for prolonged periods. Users are opting for specialized lenses that offer added features like light-adjusting properties, anti-glare coatings, and blue-light filtration to improve comfort during screen time and outdoor activities. Spectacle lenses are particularly in demand among people with refractive errors such as myopia and hyperopia, as they look for personalized solutions that align with both vision correction and style needs.

The consumer segment held a 47.8% share in 2024, fueled by increased usage of vision correction tools among younger individuals. As screen dependency increases, especially among the youth and working population, there's a clear shift toward stylish, effective, and easily accessible eyewear. Users are actively seeking convenient options, including subscription-based lens deliveries, virtual try-ons, and online prescriptions, all of which contribute to market expansion. This trend is reshaping the consumer buying experience and encouraging manufacturers to innovate with both function and fashion in mind.

North America Ophthalmic Devices Market held a 36.8% share in 2024. The region's dominance is reinforced by a strong healthcare infrastructure, heightened awareness around eye health, and willingness to adopt new technologies. An aging population with a higher risk of diseases such as glaucoma, cataracts, and retinal disorders also drives the need for advanced eye treatments. The availability of health insurance and favorable reimbursement structures supports greater access to surgical and diagnostic procedures, further increasing market penetration across the region.

Key players in the Ophthalmic Devices Market are Alcon, Bausch+Lomb, CooperVision, Johnson & Johnson, NIDEK, HOYA, TOPCON Healthcare, HEINE, Ophtec, HAAG-STREIT GROUP, ZEISS, COBURN TECHNOLOGIES, Canon, Essilor, Ziemer OPHTHALMOLOGY, and VISIONIX. Companies operating in the Global Ophthalmic Devices Market are focusing on product innovation, expanding their global reach, and improving customer engagement. They are investing heavily in research and development to bring next-generation devices with AI integration, smart wearables, and enhanced imaging features to market. Strategic partnerships with clinics, hospitals, and retail networks help enhance their distribution footprint. Firms are also emphasizing personalized solutions through digital platforms, offering remote eye exams, e-prescriptions, and virtual try-on tools. To cater to price-sensitive markets, many companies are diversifying their product portfolios with cost-effective yet advanced options.

Chapter 1 Methodology and Scope

1.1 Market scope and definition
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Data mining sources
- 1.3.1 Global
- 1.3.2 Regional/Country
1.4 Base estimates and calculations
- 1.4.1 Base year calculation
- 1.4.2 Key trends for market estimation
1.5 Primary research and validation
- 1.5.1 Primary sources
1.6 Forecast model
1.7 Research assumptions and limitations

Chapter 2 Executive Summary

2.1 Industry 360⁰ synopsis
2.2 Key market trends
- 2.2.1 Regional trends
- 2.2.2 Product trends
- 2.2.3 End use trends
2.3 CXO perspectives: Strategic imperatives
- 2.3.1 Key decision points for industry executives
- 2.3.2 Critical success factors for market players
2.4 Future outlook and strategic recommendations

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Increase in number of people suffering from ophthalmic disorders
  - 3.2.1.2 Technological advancements in products
  - 3.2.1.3 Favorable government initiatives
  - 3.2.1.4 Growing demand and preference for minimally invasive surgeries
  - 3.2.1.5 Rising adoption of contact lenses and spectacles
- 3.2.2 Industry pitfalls and challenges
  - 3.2.2.1 High cost of the ophthalmic devices
  - 3.2.2.2 Increasing adoption of refurbished ophthalmic devices
- 3.2.3 Opportunities
  - 3.2.3.1 Growing adoption of premium IOLs and phacoemulsification devices
  - 3.2.3.2 Expansion in emerging markets
3.3 Growth potential analysis
3.4 Regulatory landscape
- 3.4.1 North America
- 3.4.2 Europe
- 3.4.3 Asia Pacific
3.5 Technology and innovation landscape
- 3.5.1 Current technological trends
- 3.5.2 Emerging technologies
3.6 Consumer behavior trends
3.7 Pricing analysis, by region, 2024
3.8 Sustainability and environmental impact
- 3.8.1 Use of recyclable materials
- 3.8.2 Energy-efficient manufacturing processes
3.9 Investment landscape
3.10 Porter's analysis
3.11 PESTEL analysis
3.12 Future market trends
3.13 Value chain analysis

Chapter 4 Competitive Landscape, 2024

4.1 Introduction
4.2 Company matrix analysis
4.3 Company market share analysis
- 4.3.1 Global
- 4.3.2 North America
- 4.3.3 Europe
4.4 Competitive analysis of major market players
4.5 Competitive positioning matrix
4.6 Strategy dashboard
4.7 Key developments
- 4.7.1 Mergers & acquisitions
- 4.7.2 Partnerships & collaborations
- 4.7.3 New product launches
- 4.7.4 Expansion plans

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2034 ($ Mn)

5.1 Key trends
5.2 Vision care products
- 5.2.1 Contact lenses
  - 5.2.1.1 Soft contact lenses
  - 5.2.1.2 Rigid gas permeable lenses (RGP)
  - 5.2.1.3 Toric
  - 5.2.1.4 Other contact lenses
- 5.2.2 Spectacle lenses
5.3 Surgical devices
- 5.3.1 Cataract surgery devices
  - 5.3.1.1 Intraocular lenses
  - 5.3.1.2 Phacoemulsification devices
  - 5.3.1.3 Ophthalmic viscoelastic devices
  - 5.3.1.4 Cataract surgical Lasers
  - 5.3.1.5 IOL injectors
  - 5.3.1.6 Others cataract surgery devices
- 5.3.2 Glaucoma surgery devices
  - 5.3.2.1 Glaucoma drainage devices
  - 5.3.2.2 Glaucoma lasers
  - 5.3.2.3 Minimally invasive glaucoma surgery (MIGS)
  - 5.3.2.4 Other glaucoma surgery devices
- 5.3.3 Refractive surgery devices
  - 5.3.3.1 Excimer lasers
  - 5.3.3.2 Femtosecond lasers
  - 5.3.3.3 Other refractive surgery devices
- 5.3.4 Vitreoretinal surgery devices
  - 5.3.4.1 Photocoagulation lasers
  - 5.3.4.2 Illumination devices
  - 5.3.4.3 Vitreoretinal packs
  - 5.3.4.4 Vitrectomy machines
  - 5.3.4.5 Vitrectomy probes
  - 5.3.4.6 Other Vitreoretinal surgery devices
5.4 Diagnostic and monitoring devices
5.5 Ophthalmic accessories

Chapter 6 Market Estimates and Forecast, By End Use, 2021 - 2034 ($ Mn)

6.1 Key trends
6.2 Consumers
6.3 Hospitals
6.4 Specialty clinics
6.5 Ambulatory surgery centers
6.6 Other End uses

Chapter 7 Market Estimates and Forecast, By Region, 2021 - 2034 ($ Mn)

7.1 Key trends
7.2 North America
- 7.2.1 U.S.
- 7.2.2 Canada
7.3 Europe
- 7.3.1 Germany
- 7.3.2 UK
- 7.3.3 France
- 7.3.4 Spain
- 7.3.5 Italy
- 7.3.6 Netherlands
7.4 Asia Pacific
- 7.4.1 China
- 7.4.2 Japan
- 7.4.3 India
- 7.4.4 Australia
- 7.4.5 South Korea
7.5 Latin America
- 7.5.1 Brazil
- 7.5.2 Mexico
- 7.5.3 Argentina
7.6 MEA
- 7.6.1 South Africa
- 7.6.2 Saudi Arabia
- 7.6.3 UAE